PublicationsDiatech Admin2018-12-12T10:54:12+01:00

Publications

Leader in the development, production and
commercialisation of pharmacogenetics tests
for cancer precision medicine.

2408, 2021

Umberto Malapelle et al., Reference standards for gene fusion molecular assays on cytological samples: an international validation study.

2308, 2021

Martina Lorenzi et al., First-Line Osimertinib in Patients with EGFR-Mutant Advanced Non-Small Cell Lung Cancer: Outcome and Safety in the Real World: FLOWER Study.

1908, 2021

Sabrina Rossi et al., Uncommon single and compound EGFR mutations: clinical outcomes of a heterogeneous subgroup of NSCLC

508, 2021

Antonio Marchetti et al., Real-World Data on NGS Diagnostics: a survey from the Italian Society of Pathology (SIAPeC) NGS Network

2207, 2021

Alessandro Pancrazzi et al., Experience of Uncommon EGFR Mutation in Lung Scheme Quality Program: Discussing Risks and Opportunities for the Improvement of Laboratory Response

2207, 2021

Pamela Trillo Aliaga et al., Should temozolomide be used on the basis of O6-methylguanine DNA methyltransferase status in patients with advanced neuroendocrine tumors? A systematic review and meta-analysis.

1807, 2021

Alessandro Parisi et al., Clinicians’ Attitude to Doublet Plus Anti-EGFR Versus Triplet Plus Bevacizumab as First-line Treatment in Left-Sided RAS and BRAF Wild-Type Metastatic Colorectal Cancer Patients: A Multicenter, “Real-Life”, Case-Control Study

1307, 2021

Valentina Angerilli et al., Intratumor morphologic and transcriptomic heterogeneity in V600EBRAF-mutated metastatic colorectal adenocarcinomas

107, 2021

Cristina Morelli et al., Perfect concordance between blood-based and normal tissue-based dihydropyrimidine dehydrogenase polymorphisms suggests that pharmacogenetic screening could be contextual to tumour molecular profiling

3006, 2021

Anello Marcello Poma et al., COVID-19 autopsy cases: detection of virus in endocrine tissues

2406, 2021

Serena Ammendola et al., H3K27me3 immunostaining is diagnostic and prognostic in diffuse gliomas with oligodendroglial or mixed oligoastrocytic morphology

1506, 2021

Debora Olioso et al., Serum Exosomal microRNA-21, 222 and 124-3p as Noninvasive Predictive Biomarkers in Newly Diagnosed High-Grade Gliomas: A Prospective Study

Previous 131415 Next